Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Distinct profiles of TERT promoter mutations and telomerase expression in head and neck cancer and cervical carcinoma.

Annunziata C, Pezzuto F, Greggi S, Ionna F, Losito S, Botti G, Buonaguro L, Buonaguro FM, Tornesello ML.

Int J Cancer. 2018 Sep 1;143(5):1153-1161. doi: 10.1002/ijc.31412. Epub 2018 Apr 17.

PMID:
29603728
2.

The Role of Circulating Free DNA and MicroRNA in Non-Invasive Diagnosis of HBV- and HCV-Related Hepatocellular Carcinoma.

Pezzuto F, Buonaguro L, Buonaguro FM, Tornesello ML.

Int J Mol Sci. 2018 Mar 28;19(4). pii: E1007. doi: 10.3390/ijms19041007. Review.

3.

Extracellular vesicles derived from T regulatory cells suppress T cell proliferation and prolong allograft survival.

Aiello S, Rocchetta F, Longaretti L, Faravelli S, Todeschini M, Cassis L, Pezzuto F, Tomasoni S, Azzollini N, Mister M, Mele C, Conti S, Breno M, Remuzzi G, Noris M, Benigni A.

Sci Rep. 2017 Sep 14;7(1):11518. doi: 10.1038/s41598-017-08617-3.

4.

Frequency and geographic distribution of TERT promoter mutations in primary hepatocellular carcinoma.

Pezzuto F, Buonaguro L, Buonaguro FM, Tornesello ML.

Infect Agent Cancer. 2017 May 19;12:27. doi: 10.1186/s13027-017-0138-5. eCollection 2017. Review.

5.

Tumor specific mutations in TERT promoter and CTNNB1 gene in hepatitis B and hepatitis C related hepatocellular carcinoma.

Pezzuto F, Izzo F, Buonaguro L, Annunziata C, Tatangelo F, Botti G, Buonaguro FM, Tornesello ML.

Oncotarget. 2016 Aug 23;7(34):54253-54262. doi: 10.18632/oncotarget.9801.

6.

Update on Head and Neck Cancer: Current Knowledge on Epidemiology, Risk Factors, Molecular Features and Novel Therapies.

Pezzuto F, Buonaguro L, Caponigro F, Ionna F, Starita N, Annunziata C, Buonaguro FM, Tornesello ML.

Oncology. 2015;89(3):125-36. doi: 10.1159/000381717. Epub 2015 May 8. Review.

PMID:
25967534

Supplemental Content

Loading ...
Support Center